Bohar Bio-Technologies Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2021
- Revenue Growth -99.60%
- Profit Growth 83.61%
- Ebitda 95.16%
- Net Worth -14.45%
- Total Assets 30.07%
About Bohar Bio-Technologies
Bohar Bio-Technologies Private Limited (BBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 13 October 2017 (Seven years and three months 26 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Packaging Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vijayaraghavan Raju and Chinnaswamy Kavitha serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U21099TZ2017PTC029576
-
Company No.
029576
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
13 Oct 2017
-
Date of AGM
30 Nov 2021
-
Date of Balance Sheet
31 Mar 2021
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Bohar Bio-Technologies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vijayaraghavan Raju
|
Director | 13-Oct-2017 | Current |
|
Chinnaswamy Kavitha
|
Director | 13-Oct-2017 | Current |
Financial Performance of Bohar Bio-Technologies.
Bohar Bio-Technologies Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 99.6% decrease. The company also saw a substantial improvement in profitability, with a 83.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.45%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bohar Bio-Technologies?
Unlock access to Bohar Bio-Technologies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Perfect Coated Papers India Private LimitedVijayaraghavan Raju is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Bohar Bio-Technologies?
Unlock and access historical data on people associated with Bohar Bio-Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bohar Bio-Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bohar Bio-Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.